Insider Purchases: Inside the Buy

Tag: FMR

Digital illustration of a DNA strand fusing with glowing AI circuitry inside a futuristic lab, symbolizing Absci’s generative AI drug discovery technology.

October 9, 2025

Absci: When AI Meets Antibodies — and Insiders Can’t Resist Buying More!

AI is designing drugs, and Absci is leading the charge — with insider confidence, top-tier partners, and a cash runway through 2028. Still pre-revenue but packed with promise, this biotech might just be the next NVIDIA of antibodies.

Read entire article

Tags: Absci, ABSI, ABSI Stock, AI, AI in Biotech, AI Stocks, Almirall, AMD, Ark Invest, Biotech, Biotech Humor, Biotech Innovation, Biotech Investing, Biotech Investments, Biotech Partnerships, Biotech Stocks, Buy ABSI Stock, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, Chief Innovation Officer Buying Shares, Director Insider Buying, drug discovery, FMR, Funanc1al, Funanc1al Edge, insider purchases, institutional ownership, investing humor, Oracle, Redmile Group, speculative stocks

Your cart

Insider Purchases: Inside the Buy

Tag: FMR

October 9, 2025

Absci: When AI Meets Antibodies — and Insiders Can’t Resist Buying More!

Quick links

Contact us

About us

Follow us